224 related articles for article (PubMed ID: 35350197)
1. Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19 related olfactory disorders.
Hunter SR; Hannum ME; Pellegrino R; O'Leary MA; Rawson NE; Reed DR; Dalton PH; Parma V
medRxiv; 2022 Nov; ():. PubMed ID: 35350197
[TBL] [Abstract][Full Text] [Related]
2. Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19-related olfactory disorders.
Hunter SR; Hannum ME; Pellegrino R; O'Leary MA; Rawson NE; Reed DR; Dalton PH; Parma V
Chem Senses; 2023 Jan; 48():. PubMed ID: 36796784
[TBL] [Abstract][Full Text] [Related]
3. SCENTinel 1.0: Development of a Rapid Test to Screen for Smell Loss.
Parma V; Hannum ME; O'Leary M; Pellegrino R; Rawson NE; Reed DR; Dalton PH
Chem Senses; 2021 Jan; 46():. PubMed ID: 33773496
[TBL] [Abstract][Full Text] [Related]
4.
Parma V; Hannum ME; O'Leary M; Pellegrino R; Rawson NE; Reed DR; Dalton PH
medRxiv; 2020 Dec; ():. PubMed ID: 33330892
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and correlates of parosmia and phantosmia among smell disorders.
Pellegrino R; Mainland JD; Kelly CE; Parker JK; Hummel T
Chem Senses; 2021 Jan; 46():. PubMed ID: 34698820
[TBL] [Abstract][Full Text] [Related]
6. Using SCENTinel® to predict SARS-CoV-2 infection: insights from a community sample during dominance of Delta and Omicron variants.
Hunter SR; Zola A; Ho E; Kallen M; Adjei-Danquah E; Achenbach C; Smith GR; Gershon R; Reed DR; Schalet B; Parma V; Dalton PH
Front Public Health; 2024; 12():1322797. PubMed ID: 38660364
[TBL] [Abstract][Full Text] [Related]
7. Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination.
Hernandez AK; Landis BN; Altundag A; Fjaeldstad AW; Gane S; Holbrook EH; Huart C; Konstantinidis I; Lechner M; Macchi A; Portillo Mazal P; Miwa T; Philpott CM; Pinto JM; Poletti SC; Vodicka J; Welge-Luessen A; Whitcroft KL; Hummel T
ORL J Otorhinolaryngol Relat Spec; 2023; 85(6):312-320. PubMed ID: 37062268
[TBL] [Abstract][Full Text] [Related]
8. Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician.
Gary JB; Gallagher L; Joseph PV; Reed D; Gudis DA; Overdevest JB
Am J Rhinol Allergy; 2023 Jan; 37(1):95-101. PubMed ID: 35957578
[TBL] [Abstract][Full Text] [Related]
9. Low to moderate genetic influences on the rapid smell test SCENTinel
Hunter SR; Lin C; Hannum ME; Bell K; Huang A; Joseph PV; Parma V; Dalton PH; Reed DR
medRxiv; 2023 May; ():. PubMed ID: 37293001
[TBL] [Abstract][Full Text] [Related]
10. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training.
Liu DT; Sabha M; Damm M; Philpott C; Oleszkiewicz A; Hähner A; Hummel T
Laryngoscope; 2021 Mar; 131(3):618-623. PubMed ID: 33210732
[TBL] [Abstract][Full Text] [Related]
11. [Parosmia and phantosmia: clinical update].
Macario S; Hsieh JW; Daskalou D; Voruz F; Landis BN
Rev Med Suisse; 2022 Oct; 18(798):1837-1842. PubMed ID: 36200960
[TBL] [Abstract][Full Text] [Related]
12. Parosmia and Phantosmia: Managing Quality Disorders.
Altundag A
Curr Otorhinolaryngol Rep; 2023; 11(1):19-26. PubMed ID: 36721659
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Patient Characteristics and Olfactory Sensitivity for Trigger Odorants in Parosmia and Phantosmia.
Sekine R; Hernandez AK; Overbeck C; Hofer MK; Mori E; Hähner A; Hummel T
Laryngoscope; 2024 Apr; ():. PubMed ID: 38578016
[TBL] [Abstract][Full Text] [Related]
14. A parosmia severity index based on word-classification predicts olfactory abilities and impairment.
Hörberg T; Sekine R; Overbeck C; Hummel T; Olofsson JK
Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3695-3706. PubMed ID: 36906652
[TBL] [Abstract][Full Text] [Related]
15. [Features of olfactory impairment connected with trigeminal nerve system].
Kryukov AI; Kunelskaya NL; Zaoeva ZO; Baybakova EV; Chugunova MA; Tovmasyan AS; Panasov SA; Yanyushkina ES; Manaenkova EA; Nikitkina YY; Panova TN; Kishinevskii AE
Vestn Otorinolaringol; 2024; 89(2):33-39. PubMed ID: 38805461
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and associated factors of qualitative olfactory dysfunction.
Eo TS; Lee HY; Cho HJ; Yoon JH; Rha MS; Kim CH
Rhinology; 2023 Oct; 61(5):432-440. PubMed ID: 37243721
[TBL] [Abstract][Full Text] [Related]
17. Euosmia: a rare form of parosmia.
Landis BN; Frasnelli J; Hummel T
Acta Otolaryngol; 2006 Jan; 126(1):101-3. PubMed ID: 16308262
[TBL] [Abstract][Full Text] [Related]
18. Trigeminal function in patients with COVID-associated olfactory loss.
Juratli JH; Garefis K; Konstantinidis I; Hummel T
Eur Arch Otorhinolaryngol; 2024 May; 281(5):2403-2411. PubMed ID: 38127097
[TBL] [Abstract][Full Text] [Related]
19. Qualitative smell/taste disorders as sequelae of acute COVID-19.
Ercoli T; Masala C; Pinna I; Orofino G; Solla P; Rocchi L; Defazio G
Neurol Sci; 2021 Dec; 42(12):4921-4926. PubMed ID: 34557966
[TBL] [Abstract][Full Text] [Related]
20. Well-being in patients with olfactory dysfunction.
Mai Y; Menzel S; Cuevas M; Haehner A; Hummel T
Physiol Behav; 2022 Oct; 254():113899. PubMed ID: 35809697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
